Learn more from WebMD about connective tissue disease, including Diagnosis, Types, symptoms, causes of various forms, available treatment options and Prevention.

Today, AliveDx announces it has submitted 510 (k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex® Connective Tissue Diseases (CTDplus) microarray. The ...

The MosaiQ AiPlex CTDplus assay enables a syndromic approach and accurate serological evaluation of Rheumatoid Arthritis (RA) and connective tissue diseases (CTD) for healthcare providers.

The incidence of all musculoskeletal symptoms and connective-tissue diseases was similar in both the group authenticated by biopsy and the group not so studied.

Anti-inflammatory medications are a cornerstone of treatment for mixed connective tissue disease (MCTD) but your diet also is important. Eating a healthy, balanced diet may help prevent flare-ups ...

AliveDx’s MosaiQ AiPlex CTDplus multiplex assay receives IVDR-CE mark to aid in diagnosing systemic autoimmune rheumatic diseases and streamline laboratory workflow ...

The MosaiQ AiPlex CTDplus assay enables a syndromic approach and accurate serological evaluation of Rheumatoid Arthritis (RA) and systematic connective tissue diseases (CTD) for healthcare providers.

Diagnosing these conditions is complex due to overlapping clinical symptoms and high rates of co-occurrence among a range of connective tissue diseases1.

The MosaiQ AiPlex CTDplus assay enables a syndromic approach and accurate serological evaluation of Rheumatoid Arthritis (RA) and systematic connective tissue diseases (CTD) for healthcare providers.

For connective tissue diseases, the multiplex assay is designed to rapidly detect and identify up to 1275 disease markers per hour.